Ling S, Dexter A, Race A, Sharma S, Hamm G, Polanska U
Dis Model Mech. 2025; 18(2).
PMID: 40019006
PMC: 11892681.
DOI: 10.1242/dmm.050804.
Wang Z, Chang H, Zhao Q, Gou W, Li Y, Tu Z
Chin Herb Med. 2025; 17(1):31-40.
PMID: 39949808
PMC: 11814259.
DOI: 10.1016/j.chmed.2024.04.005.
Shamraeva M, Visvikis T, Zoidis S, Anthony I, Nuffel S
J Am Soc Mass Spectrom. 2024; 35(12):2801-2814.
PMID: 39455427
PMC: 11622239.
DOI: 10.1021/jasms.4c00324.
Miao Z, Sun Y, Feng Z, Wu Q, Yang X, Wang L
J Anim Sci Biotechnol. 2024; 15(1):105.
PMID: 39098913
PMC: 11299266.
DOI: 10.1186/s40104-024-01061-0.
Qiao Y, Tian F, Yu L, Zhao J, Zhai Q, Chen W
Foods. 2024; 13(14).
PMID: 39063297
PMC: 11276274.
DOI: 10.3390/foods13142213.
Highly Sensitive Spatial Glycomics at Near-Cellular Resolution by On-Slide Derivatization and Mass Spectrometry Imaging.
Cumin C, Gee L, Litfin T, Muchabaiwa R, Martin G, Cooper O
Anal Chem. 2024; 96(28):11163-11171.
PMID: 38953530
PMC: 11256013.
DOI: 10.1021/acs.analchem.3c05984.
Super-resolution techniques for biomedical applications and challenges.
Shin M, Seo M, Lee K, Yoon K
Biomed Eng Lett. 2024; 14(3):465-496.
PMID: 38645589
PMC: 11026337.
DOI: 10.1007/s13534-024-00365-4.
Oxidized low-density lipoprotein changes the inflammatory status and metabolomics profiles in human and mouse macrophages and microglia.
Sun Y, Liang J, Xu J, Zhou K, Fu C, Chen S
Heliyon. 2024; 10(7):e28806.
PMID: 38617955
PMC: 11015420.
DOI: 10.1016/j.heliyon.2024.e28806.
Exploration of the hypoglycemic mechanism of Fuzhuan brick tea based on integrating global metabolomics and network pharmacology analysis.
Xiang X, You S, Zeng Z, Xu J, Lin Y, Liu Y
Front Mol Biosci. 2024; 10:1266156.
PMID: 38304230
PMC: 10830801.
DOI: 10.3389/fmolb.2023.1266156.
Cell and rat serum, urine and tissue metabolomics analysis elucidates the key pathway changes associated with chronic nephropathy and reveals the mechanism of action of rhein.
Wang L, Yu X, Li H, He D, Zeng S, Xiang Z
Chin Med. 2023; 18(1):158.
PMID: 38041193
PMC: 10691122.
DOI: 10.1186/s13020-023-00862-1.
Sample Preparation Method for MALDI Mass Spectrometry Imaging of Fresh-Frozen Spines.
Bender K, Wang Y, Zhai C, Saenz Z, Wang A, Neumann E
Anal Chem. 2023; 95(47):17337-17346.
PMID: 37886878
PMC: 10688227.
DOI: 10.1021/acs.analchem.3c03672.
rMSIfragment: improving MALDI-MSI lipidomics through automated in-source fragment annotation.
Baquer G, Semente L, Rafols P, Martin-Saiz L, Bookmeyer C, Fernandez J
J Cheminform. 2023; 15(1):80.
PMID: 37715285
PMC: 10504721.
DOI: 10.1186/s13321-023-00756-2.
deficiency induces a metabolic shift in MEFs that can be manipulated by the NAD precursor nicotinamide riboside.
Anugula S, Li Z, Li Y, Hendriksen A, Christensen P, Wang L
Heliyon. 2023; 9(6):e17392.
PMID: 37484291
PMC: 10361373.
DOI: 10.1016/j.heliyon.2023.e17392.
Phosphatidylinositol metabolism of the renal proximal tubule S3 segment is disturbed in response to diabetes.
Rietjens R, Wang G, van der Velden A, Koudijs A, Avramut M, Kooijman S
Sci Rep. 2023; 13(1):6261.
PMID: 37069341
PMC: 10110589.
DOI: 10.1038/s41598-023-33442-2.
Comparison of Local Metabolic Changes in Diabetic Rodent Kidneys Using Mass Spectrometry Imaging.
Zhang X, Liu Y, Yang S, Gao X, Wang S, Wang Z
Metabolites. 2023; 13(3).
PMID: 36984764
PMC: 10060001.
DOI: 10.3390/metabo13030324.
Treatment of tubular damage in high-fat-diet-fed obese mice using sodium-glucose co-transporter inhibitors.
Saitoh S, Takaki T, Nakajima K, Wo B, Terashima H, Shimo S
PLoS One. 2023; 18(2):e0281770.
PMID: 36780539
PMC: 9925073.
DOI: 10.1371/journal.pone.0281770.
Youth versus adult-onset type 2 diabetic kidney disease: Insights into currently known structural differences and the potential underlying mechanisms.
Tommerdahl K, Kendrick J, Nelson R, Bjornstad P
Clin Sci (Lond). 2022; 136(21):1471-1483.
PMID: 36326718
PMC: 10175439.
DOI: 10.1042/CS20210627.
Suramin prevents the development of diabetic kidney disease by inhibiting NLRP3 inflammasome activation in KK-Ay mice.
Oda K, Miyamoto S, Kodera R, Wada J, Shikata K
J Diabetes Investig. 2022; 14(2):205-220.
PMID: 36308062
PMC: 9889613.
DOI: 10.1111/jdi.13930.
Potential progression biomarkers of diabetic kidney disease determined using comprehensive machine learning analysis of non-targeted metabolomics.
Hirakawa Y, Yoshioka K, Kojima K, Yamashita Y, Shibahara T, Wada T
Sci Rep. 2022; 12(1):16287.
PMID: 36175470
PMC: 9523033.
DOI: 10.1038/s41598-022-20638-1.
Mitochondrial Dysfunction in Individuals with Diabetic Kidney Disease: A Systematic Review.
Flemming N, Pernoud L, Forbes J, Gallo L
Cells. 2022; 11(16).
PMID: 36010558
PMC: 9406893.
DOI: 10.3390/cells11162481.